CONFORMATIONAL AND STRUCTURAL CHARACTERISTICS OF PEPTIDES BINDING TO HLA-DR MOLECULES

被引:0
|
作者
HILL, CM [1 ]
HAYBALL, JD [1 ]
ALLISON, AA [1 ]
ROTHBARD, JB [1 ]
机构
[1] IMMUNOL PHARMACEUT CORP,855 CALIF AVE,PALO ALTO,CA 94304
来源
JOURNAL OF IMMUNOLOGY | 1991年 / 147卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A fundamental characteristic of MHC class I and class II proteins is their unusual capacity to form stable complexes with a wide spectrum of peptide ligands. In this study, sets of peptide analogues containing long chain-biotinylated lysine individually substituted for each amino acid in the sequence have been used to explore the structural requirements for the formation of peptide-MHC class II protein complexes. Based on the ability of the analogs to bind both the MHC protein and fluorescent streptavidin, receptor contact residues were identified and from their spacing the conformation of the bound peptides could be inferred. Six separate peptides were studied; three defined by HLA-DR1Dw1-restricted T cells, and three identified by T cells restricted through alleles other than HLA-DR1Dw1. The similar patterns of fluorescent signals observed when the former three peptides were studied indicated that they shared conformational features when bound to HLA-DR1Dw1. In contrast when the latter three peptides were examined, the data indicated that they shared some but not all of the conformational features characteristic of the peptides known to elicit HLA-DR1Dw1-restricted T cells. When the peptide sequences were aligned based on the critical contact residues, two positions of structural homology were apparent. In each sequence, an amino acid with a bulky hydrophobic side chain could be identified separated by four residues from a small amino acid. These minimal structural requirements were consistent with recent experiments demonstrating that only a small number of side chains in the peptide were necessary for binding to the MHC protein.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 50 条
  • [1] INTERACTIONS BETWEEN IMMUNOGENIC PEPTIDES AND HLA-DR MOLECULES
    ROTHBARD, JB
    BUSCH, R
    [J]. IMMUNOLOGIC RESEARCH, 1990, 9 (03) : 178 - 189
  • [2] Molecular Analysis of Thymopentin Binding to HLA-DR Molecules
    Liu, Zuojia
    Zheng, Xiliang
    Wang, Jin
    Wang, Erkang
    [J]. PLOS ONE, 2007, 2 (12):
  • [3] Binding of mutated Ras- and p53-derived peptides to HLA-DR molecules
    Murakami, S
    Yokomizo, H
    Matsushita, S
    Ogawa, M
    Nishimura, Y
    [J]. IMMUNOLOGY LETTERS, 1996, 49 (03) : 149 - 153
  • [4] CONSERVED AND ALLELE SPECIFIC ANCHORS IN HLA-DR BINDING PEPTIDES
    SINIGAGLIA, F
    BOLIN, D
    VALSASNINI, P
    HAMMER, J
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 92 - 92
  • [5] COMPLEXITY OF ANTIBODY-BINDING EPITOPES ON HLA-DR MOLECULES
    FU, X
    KARR, RW
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A303 - A303
  • [6] HLA-DR binding analysis of peptides from islet antigens in IDDM
    Geluk, A
    van Meijgaarden, KE
    Schloot, NC
    Drijfhout, JW
    Ottenhoff, THM
    Roep, BO
    [J]. DIABETES, 1998, 47 (10) : 1594 - 1601
  • [7] Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules
    Fridkis-Hareli, M
    Strominger, JL
    [J]. JOURNAL OF IMMUNOLOGY, 1998, 160 (09): : 4386 - 4397
  • [8] Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR
    Cobb, Brian A.
    Kasper, Dennis L.
    [J]. GLYCOBIOLOGY, 2008, 18 (09) : 707 - 718
  • [9] Specificity of cartilage matrix peptides for rheumatoid arthritis associated HLA-DR molecules
    Kirschmann, DA
    Howard, SC
    Guerassimov, A
    Poole, AR
    Schwartz, BD
    Woulfe, SL
    [J]. FASEB JOURNAL, 1996, 10 (06): : 2740 - 2740
  • [10] STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF HLA-DR MOLECULES CIRCULATING IN THE SERUM
    JENDRO, M
    GORONZY, JJ
    WEYAND, CM
    [J]. AUTOIMMUNITY, 1991, 8 (04) : 289 - 296